Wall Street expects a year-over-year decline in earnings on higher revenues when Gilead Sciences (GILD) reports results for ...

Gilead Sciences, Inc. (NASDAQ:GILD) is among the 12 Most Profitable NASDAQ Stocks to Buy Right Now. On January 27, Truist ...

Gilead Sciences (NasdaqGS:GILD) reported positive Phase 3 ASCENT-04/KEYNOTE-D19 results for Trodelvy plus Keytruda in ...

We came across a bullish thesis on Gilead Sciences, Inc. on Disruptive analytics’s Substack by Magnus Ofstad. In this article ...

The Testaments, a new series set in the universe of The Handmaid's Tale shared a first look and release date today.

Gilead Sciences advances global biopharmaceutical research as part of broader healthcare activity linked to the nasdaq 100 ...

This disclosure is particularly significant for investors tracking the Cymabay integration, as it will encompass detailed sales figures for a complete fiscal year under Gilead's ownership. The data ...

Gilead gave the money to doctors who spoke at HIV Speaker Program events in the form of honoraria payments, meals and travel expenses, according to the U.S. Attorney's Office in Manhattan, which said ...

Learn more about whether Arrowhead Pharmaceuticals, Inc. or Gilead Sciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

US biotech Gilead Sciences today announced that its Trodelvy (sacituzumab govitecan-hziy) has now been added to the National ...